Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Cabrera
Alberto Canizo Cabrera, Yunlin TW
| Patent application number | Description | Published |
|---|---|---|
| 20090046497 | System and method for reducing critical current or magnetic random access memory - A system and a method for reducing critical current of magnetic random access memory (MRAM) are disclosed. The magnetic device includes at least a pinned layer, a spacer layer and a free layer, and the material of the pinned layer and the free layer is perpendicularly anisotropic ferrimagnetic. The spacer layer is an insulator. By the modified Landau-Lifshitz-Gilbert equations, the varying trend of the critical current can be estimated. | 02-19-2009 |
Alberto Canizo Cabrera, Douliou City TW
| Patent application number | Description | Published |
|---|---|---|
| 20080205123 | MAGNETIC RANDOM ACCESS MEMORY AND METHOD OF REDUCING CRITICAL CURRENT OF THE SAME - A magnetic random access memory includes a substrate, a free layer and a spacer layer. The substrate and the free layer are made of a vertical anisotropy ferrimagentic thin film. The spacer layer is sandwiched between the substrate and the free layer and is made of an insulating layer. The method uses a modified Landau-Lifshitz-Gilbert equation to obtain a critical current value as a function of exchange coupling constant. The critical current value is predictable under several external magnetic fields being applied. When the exchange coupling constant is proportionally varied, the critical current value is reduced to a third of its original value under an optimum state. | 08-28-2008 |
Gustavo Cabrera, Temuco CL
| Patent application number | Description | Published |
|---|---|---|
| 20090107914 | Novel plant gene and uses thereof - A novel gene isolated from | 04-30-2009 |
| 20100310686 | EXTRACTS OF DESCHAMPSIA ANTARCTICA DESV, WITH ANTINEOPLASTIC ACTIVITY - The present disclosure provides a novel antineoplastic extract obtained from | 12-09-2010 |
| 20110177178 | Extracts of Deschampsia antarctica Desv. with antineoplastic activity - This invention describes antineoplastic compound derived from | 07-21-2011 |
Michel Cabrera, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20090170729 | Method and a machine for ex situ fabrication of low and medium integration biochip arrays - A method of ex situ fabrication of at least one biochip, the method being of the type consisting in projecting onto a substrate a microvolume of reagent comprising at least one probe diluted in a suitable solvent so as to form, after the solvent has been eliminated, a spot comprising said probe, the method consisting in using a microprojection device comprising at least one tank in which the reagent is stored, and at least one source of gas under pressure put into communication with the tank, and in projecting the microvolume of reagent through an ejection nozzle under drive from the pressure exerted by the gas on the reagent. | 07-02-2009 |
| 20100236433 | PAD MICROPRINTING DEVICE AND METHODS, AND PAD FOR THIS DEVICE - This pad microprinting device comprises: | 09-23-2010 |
| 20110174634 | MACHINE AND METHOD FOR MACHINING A PART BY MICRO-ELECTRICAL DISCHARGE MACHINING - The invention relates to a machine for machining a part by micro-electrical discharge machining, said machine comprising a mechanism ( | 07-21-2011 |
Osmir Blanco Cabrera, Ciudad De La Habana CU
| Patent application number | Description | Published |
|---|---|---|
| 20110256214 | SINGLE-TIME VACCINES - The invention is related to the field of vaccines. The technical objective is to obtain novel unitemporal therapeutic and prophylactic vaccines (single time vaccination strategy) using simultaneously one or more mucosal doses and one parenteral dose where the use of potent mucosal adjuvants are essential, preferable the Cochleate (AFCo I, Adjuvant Finlay Cochleate 1). The incorporation or co-administration by parenteral and mucosal routes of non-related PL antigens (heterologous), and/or the additional use of delivery systems like Aluminum, Chitosan or oil/water emulsions by parenteral application is also included in this invention. The induction of cellular immune responses than including systemic specific IgG and secretory specific IgA is obtained with at least two simultaneously doses. So, this unitemporal strategy is applicable to obtaining new unique or multiples vaccines (several mucosal vaccine antigens with the corresponding parenteral combine vaccine) in the pharmaceutical industry which permit to increase vaccine coverage and reduce the time-cost of vaccine campaigns. | 10-20-2011 |